Highlights
1 patent
About
Medical Cannabis Drugs
TALENT Biotechs develops cannabidiol-based therapies.TALENT screens and locates pharmaceutical and medical technologies patented in the global market and leverages the development process of research and clinical trials throughPhase II into a Phase IIIstarting point. TALENThas suggestedthe use of cannabidiol for the prevention and treatment of graft-versus-host disease, which is a major cause of morbidity and mortality withallogeneic hematopoietic stem cell transplantation. TALENT Biotechs has been acquired by Kalytera Therapeutics, Beverly, Massachusetts, United States.
Identity
| Name | TALENT Biotechs |
|---|---|
| Slug | talent-biotechs |
| Type / kind | startup |
| Crunchbase ID | talent-biotechs |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwN2azY8KDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Kalytera Therapeutics on Feb 2017 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Bnei Brak |
| HQ address | Barukh Hirsch Street 14, Bnei Brak, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
pharmaceuticalscannabisoncologypharma-companies
Funding
| Total raised | — |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}